Gagez AL, Paul F, Alaterre E, Gouilleux-Gruart V, et al. Angiogenic factors could help us to define patients obtaining complete response with undetectable minimal residual disease in untreated CLL patients treated by FCR: results from the CLL2010FMP, a FILO study. Leuk Lymphoma 2021;62:3160-3169.
PMID: 34806520